Re: van Dijk et al: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE trial Reply

Author(s):
Dijk, E.H.C. van (0000-0002-6351-7942); Fauser, S.; Breukink, M.B.; Blanco-Garavito, R.; Keunen, J.E.E.; Groenewoud, J.M.M.; Peters, P.J.H.; Dijkman, G.; Souied, E.H.; MacLaren, R.E.; Querques, G.; Downes, S.M.; Hoyng, C.B.; Boon, C.J.F.
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-01-31
Language
English
Is part of
Ophthalmology: Journal of The American Academy of Ophthalmology (2019), Vol. 126, no. 1, p. E11-E11
hdl
1887/121077